HIGHLIGHTS
- who: January et al. from the Medical University of Bialystok, Poland have published the paper: Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial, in the Journal: (JOURNAL)
- what: The authors report the overall results of 100 COVID-19 outpatients who completed the study, and the concluding results validates the preliminary results the authors reported earlier, implying the possible therapeutic role of quercetin supplementation in patients at early-stage of COVID-19. count were evaluated, and treatment to be taken at home prescribed as per randomization . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.